Aclaris Therapeutics
ACRS
3.38
-0.02
-0.71%
Aclaris Therapeutics
US · ACRS
#3750 by market cap
Listed 2015
3.38
-0.02
-0.71%
Live - 5344 symbols - heartbeat 140s ago
· 2026-10-08 10:00
Pre-market
3.44
+1.11%
After-hours
3.46
+1.76%
Overnight
3.39
-0.29%
- Market cap
- 496.94M
- P/E (TTM)i
- -5.82
- P/Bi
- 3.99
- EPSi
- -0.53
- Div yieldi
- 0.00%
- 52W posi
- 34%
Reader sentiment
Are you bullish or bearish on ACRS?
Anonymous reader poll. Unscientific, not investment advice.
About Aclaris Therapeutics
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.
- Founded
- 2012
- CEO
- Dr. Neal Walker, D.O.
- Employees
- 73
- Headquarters
- Wayne, Pennsylvania, United States of America
- Fiscal year end
- 12-31
- Website
- aclaristx.com
Company profile
- Exchange
- US
- Symbol
- ACRS
- Market-cap rank
- #3750
- Listing date
- 2015-10-07
- Market cap
- 496.94M
- Float cap
- 341.55M
- Shares out
- 147.20M
- Float shares
- 101.17M
Sectors & themes
Quote time 2026-10-08 10:00:33 · For reference only, not investment advice and not tailored to your situation.